logo
Biosimilar biologics: never identical but close enough
Shedding a little light on posttransfusion purpura
Methods for the selection of platelet products for alloimmune-refractory patients
Green plasma
Biosimilar granulocyte–colony-stimulating factor for mobilization of autologous peripheral blood stem cells in pediatric hematology-oncology patients
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation
Successful treatment of severe immune hemolytic anemia after allogeneic stem cell transplantation with bortezomib: report of a case and review of literature
Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency
Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma
Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large Medicare databases during 2011 through 2012
Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets
Metabolomic analysis of platelets during storage: a comparison between apheresis- and buffy coat–derived platelet concentrates
Treatment with fibrinogen γ-chain peptide-coated, adenosine 5′-diphosphate–encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia
Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light
Development of a bifunctional filter for prion protein and leukoreduction of red blood cell components
Pathogen reduction by ultraviolet C light effectively inactivates human white blood cells in platelet products
Comparison of two platelet transfusion strategies to minimize ABO-nonidentical transfusion, outdating, and shortages using a computer-simulated “virtual blood bank”
Immunohematologic tolerance of chronic transfusion exchanges with erythrocytapheresis in sickle cell disease
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses
Predonation screening of candidate donors and prevention of window period donations
Comparison of three noninvasive methods for hemoglobin screening of blood donors
Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers
What is the meaning of a nonresolved viral nucleic acid test–reactive minipool?
Blood reference materials from macaques infected with variant Creutzfeldt-Jakob disease agent
Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population
An age-dependent ABO discrepancy between mother and baby reveals a novel Aweak allele
New RHD variant alleles
Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
Cell-based therapies for cardiac disease: a cellular therapist's perspective
Hematopoietic stem cell transplant–associated thrombotic microangiopathy: review of pharmacologic treatment options
Thomas F. Zuck
Transfusion and inpatient 30-day mortality